Evotec Investor Day Presentation Deck

evotec • "Free options" through alliance building • Selected risk-shared alliances reduce upfront and research payments in exchange for milestones and royalties PAGE 19 We optimise long-term value generation Co-owning "blueprint" Alliance building R&D cost Ø € 5-10 m per project Performance-based payments to Evotec (Illustrative) Milestone Payments Ø € 200 m per project Upfront MS 1 and/or research payments € 1-50 m MS 2 MS 3 MS 4 Clinical Start MS 5 MS 6 MS 7 Ø 8-10% royalties Total Royalties & Sales Milestone

View entire presentation